OVERVIEW

Systemic Therapies for the Management of Advanced and Metastatic Gastric and Gastroesophageal Cancers: Agents and Regimens is organized by Med Learning Group and will be held from Oct 12, 2018 - Oct 12, 2019.

The target audience for this medical event is designed to educate oncologists, oncology nurses and other health care providers involved in the care of patients with advanced/metastatic gastric cancer and gastroesophageal junction adenocarcinoma. This CME Conference has been approved for a maximum of 1 AMA PRA Category 1 Credits.

Program Overview:
This infographic enduring activity will cover the diagnosis, treatment and management of patients with advanced and metastatic gastric and gastroesophageal cancers.

Learning Objectives:
Upon completion of the program, attendees should be able to:
• Describe the tissue changes characteristic of gastric and gastroesophageal cancers
• Review clinical trial data on the efficacy and safety of systemic treatment options across all lines of therapy for patients with advanced and metastatic gastric and gastroesophageal junction cancers
• Discuss guideline-recommended therapeutic regimens across all lines of treatment for patients with advanced and metastatic gastric and gastroesophageal junction cancer